key: cord-0966434-uxuuiao4
authors: Johnson, Robert E.; Foy, Trayvon E.; Ellingsen, Taylor A.; Nelson, J. Luke; Dillon, Jasjit K.
title: Odontogenic infections: Disease burden during COVID-19 at a single institution
date: 2020-10-16
journal: J Oral Maxillofac Surg
DOI: 10.1016/j.joms.2020.10.015
sha: f59c11d3600cf71a430b572d09176cfc059a0252
doc_id: 966434
cord_uid: uxuuiao4

PURPOSE: The purpose of this study was to document the effect of COVID-19 on patients presenting to University of Washington Oral and Maxillofacial Surgery (UW OMS) with an odontogenic infection. MATERIALS AND METHODS: The investigators designed a retrospective cohort study and enrolled a sample of 889 subjects who presented for an odontogenic infection from March 19(th) to June 18(th) in the years 2017, 2018, 2019, and 2020. The primary predictor variable was OMS consultation for an odontogenic infection during a non-COVID-19 (2017, 2018, and 2019) year (control) or during the COVID-19 pandemic in 2020 (experimental). The primary outcome variable was treatment rendered. Appropriate univariate and bivariate statistics were computed, and the level of significance was set at .05 for all tests. RESULTS: There was no significant difference in the incidence of OMS consults in the two cohorts (p>.05). The number of patients presenting to the UW emergency department (ED) for an odontogenic infection decreased from an average of 246 in non-COVID years to 151 in 2020. Patients in the experimental cohort were more likely (55 versus 30.0%; p=.04) to present primarily to UW than a dentist and were less likely to undergo an incision and drainage (I&D) (70.0 versus 88.8%; p=.04), aerosol generating procedure (AGP) (70.0 versus 88.8%; p=.04), and I&D in the ED (15.0 versus 41.3%; p=.03). CONCLUSION: The investigators did not find evidence of increased hospital or ED burden by odontogenic infections during the COVID-19 pandemic.

Odontogenic infections can present as low-grade and localized to severe and life-threatening.

Their management is a critical function of an oral and maxillofacial surgeon (OMS). 1,2 Treatment of odontogenic infections by general dentists and specialists in the community is preferred to prevent disease progression; however, symptoms and signs such as dysphagia, dyspnea, extension beyond alveolus, fever, trismus, and systemic features warrant referral to an OMS and potential management within a hospital facility. 3 In response to the COVID-19 pandemic in the state of Washington (WA), Governor Jay Inslee issued Proclamation 20-24 on March 19, 2020, prohibiting dentists from providing procedures that, if delayed, were not anticipated to cause patient harm within the next 3 months. 4 The proclamation immediately took effect to stand for 2 months until May 18, 2020, with the understanding that the endpoint may be extended (though, it ultimately was not,) given the dynamic nature of pandemic response. Although dental practices were permitted to treat nonelective pathology during this time, existential barriers including COVID-19 compliant personal protective equipment (PPE), economic volatility, patient trepidation, and gubernatorial stay-athome order (March 23, 2020)-in addition to typically reported barriers to care-made treatment efforts increasingly unlikely. 5 COVID-19 transmission occurs via aerosols, therefore assessment of aerosol generating procedures (AGPs) was of interest. 6 The COVID-19 pandemic and humanity's response is unprecedented in the modern era, and as such, data to support medical and legislative actions are both scarce and urgent.

J o u r n a l P r e -p r o o f 4 The purpose of this study was to measure and document the effect of the COVID-19 pandemic on patients presenting to the University of Washington Department of Oral and Maxillofacial Surgery (UW OMS) with an odontogenic infection within the 3 month period following restriction of elective dental procedures, and comparing these data to the same 3 month period in the 3 years prior. The aim is to compare the disease burden of odontogenic infections in the hospital setting when extreme measures are implemented in response to a state of emergency.

The authors hypothesize that the treatment of odontogenic infections managed by UW OMS during the COVID-19 response in 2020 will be different than the treatment of odontogenic infections managed during the same time periods in 2017, 2018, and 2019 serving as a control.

The researchers designed and implemented a retrospective cohort study. The study sample was March 19 th -June 18 th , 2020 in the experimental cohort. Subjects were excluded from the study if the infection was not odontogenic or their chart was incomplete.

The primary predictor variable was OMS consultation for odontogenic infection during the indicated 3 months of the COVID-19 response in 2020, or in one of same timeframes in the 3 years previous (2017, 2018, or 2019) . The primary outcome variable was treatment rendered.

Other variables included the number of patients presenting for dental infections to the ED, demographics: sex, age, county of residence; and, potential risk factors for COVID-19 morbidity: advanced age (≥ 65), long-term care facility, chronic lung disease other than asthma, asthma, cardiac disease, immunocompromise, severe obesity (BMI ≥40), diabetes mellitus, chronic kidney disease with dialysis, liver disease, ace-inhibitor (ACE-I) or angiotensin II Once subjects were identified by ICD-10 codes and date range queries, individual chart reviews were conducted by calibrated members of the research team to ensure satisfaction of inclusion and exclusion criteria and to facilitate collection of the variables. All data was de-identified and kept in a secure Excel (Microsoft, Redmond, WA) spreadsheet accessible to the investigators only. Following data collection, the primary author (RJ) randomized 25 charts to cross-check for consistency. Descriptive statistics were stratified by non-COVID-19 (control) and . SPSS (SPSS, Inc, Chicago, Il) was used for data analysis and the level of significance for all tests was defined as .05.

The study sample was composed of 889 subjects whom presented to UW ED with an odontogenic infection during March 19 th -June 18 th in the years 2017, 2018, 2019, and 2020. The number of patients presenting to the UW ED (Table 1) were ≥65 years of age at time of treatment, all of whom presented in a year other than 2020 (p>.05). No statistical difference was found in demographics of subjects between the two cohorts. The 3 patients whom did not receive COVID-19 testing in 2020 were also the first 3 patients seen in that year's cohort, prior to institutional testing standardization. None (0.0%) of the subjects were COVID-19 positive. Table 3 describes the infections. Supplemental #1 lists all 66 ICD-10 codes that were used to query patient charts; however, only 6 ICD-10 codes resulted with subjects. It should be noted that more than 1 ICD-10 code described multiple patients. In descending order of prevalence:

K12.2 cellulitis and abscess of mouth (n=57), K02.9 dental caries, unspecified (n=52), L02.01 cutaneous abscess of the face (n=14), L03.211 cellulitis of face (n=14), K01.1 impacted teeth (n=10), and K04.1 necrosis of dental pulp (n=6). The experimental cohort experienced more infections involving 4 or 5 spaces (25.0%), versus the control cohort (5.0%); however, the difference in number of anatomical spaces implicated was not statistically significant (p>.05).

Submandibular space was the most commonly implicated space, involved in 48.0% of all subject infections, followed by submental space (26.0%) and buccal space (20.0%). Third molars were most likely (10.0%) to be a source of infection in the maxilla, followed by canines (9.0%) and second premolars and lateral incisors (both 6.0%). Second molars were most commonly (33.0%) J o u r n a l P r e -p r o o f identified as a source of infection in the mandible, followed by first molars (27.0%) and third molars (20.0%). Table 4 describes the treatment course of infections by cohort. OMS was more likely to be consulted during COVID-19 (13.3% of patients presenting to UW with an odontogenic infection versus 10.8% in non-COVID-19 years; however, this relationship was not statistically significant p=.39). There was no significant difference in the distance patients had to travel for treatment, as described by percent of patients whom reside in the same county (King) as HMC and UWMC.

Patients were found to be more likely to present initially to HMC or UWMC during the pandemic (55.0% versus the 3 years prior 30.0%; p=.04) in lieu of an outside hospital, dental office, urgent care clinic, or primary care physician. There were no differences in length of stay (LOS), rates of admission, ICU stay, extraction(s), I&Ds in clinic or the OR, or antibiotics.

Patients treated by OMS for an odontogenic infection during the COVID-19 pandemic were less likely to undergo an I&D than those patients treated in the 3 years prior (70.0 versus 88.8%, p=.04). No patients in the sample underwent an AGP other than I&D, therefore, those same patients were less likely to undergo an AGP by the same margin (70.0 versus 88.8%; p=.04).

Patients treated during the pandemic response had a further decreased chance of undergoing an I&D in the emergency department (15.0 versus 41.3%; p=.03).

The investigators designed this study with the purpose of measuring and documenting the effect of COVID-19 on patients presenting to UW for treatment of an odontogenic infection. It was J o u r n a l P r e -p r o o f hypothesized that the treatment of odontogenic infections managed by UW OMS would be different during the COVID-19 pandemic response than in the 3 years previous. The aim of this study was to report and compare the disease burden of odontogenic infections in the hospital setting during the pandemic response, which included restricting elective dentistry.

Subjects in the COVID-19 cohort were less likely to undergo I&D (70.0 versus 88.8%, p=.04), AGP (70.0 versus 88.8%, p=.04), and I&D in the ED (15.0 versus 41.3%; p=.03). These data represent differences in treatment between the 2 cohorts; therefore, the null hypothesis was rejected.

COVID-19 transmission occurs via aerosols, therefore assessment of aerosol generating procedures (AGPs) including tracheotomy, tracheostomy care, airway suctioning, abscess drainage, wound irrigation, use of ultrasonic/piezoelectric devices, and use of high-speed handpieces, was of particular interest. 7, 8 AGPs also require additional PPE, of which supply was strained especially during the early months of the pandemic.

During COVID-19, 13.3% of patients presenting to UW with an odontogenic infection were consulted by OMS versus 10.8% in non-COVID-19 years; however, this relationship was not statistically significant (p=.39). An average of 246 patients presented to the ED with an odontogenic infection in non-COVID years versus 151 during 2020. It is unclear why fewer patients presented to the ED during COVID-19. The authors postulate that patients may have avoided UW due to its widely broadcasted involvement in the pandemic response, were treated in the community by dentists or physicians with analgesics and antibiotics, or possibly less likely J o u r n a l P r e -p r o o f to visit the ED for pain medication related to dental pain. Interestingly, although there was no difference in the incidence of OMS consultation and an overall fewer number of patients presented to the ED in 2020, there was an increased likelihood (55.0 versus 30.0%; p=.04) that patients would present first to HMC or UWMC in lieu of an outside hospital, dental office, urgent care clinic, or primary care physician.

Only 1 (5.0%) patient in the experimental group presented to a dentist prior to HMC or UWMC, whereas 13 (16.3%) patients did so in the 3 years previous (p=.19). Strained access to COVID-19 compliant PPE, staffing difficulties, lack of government and professional organization protocols, and general pandemic related anxieties likely hindered the ability of community dentists to provide emergent care.

A non-significant (p=.07) finding of more severe infections as described by the number of spaces implicated was noted during COVID-19. It is possible that limited access to emergent dental care resulted in prolonged disease course before presentation. This may also account for a decreased likelihood of undergoing an I&D in the ED, as more aggressive infections require definitive treatment in a more controlled setting such as the OR.

Hospital resources and the potential to be overwhelmed was of paramount concern when preparing for the COVID-19 response, and legislative prohibition of elective dentistry had the potential to divert infections that would typically be managed in dental practices to further burden hospitals. Despite a greater likelihood of presenting primarily to the ED, this J o u r n a l P r e -p r o o f investigation did not find evidence of increased hospital burden from odontogenic infections during the studied period of the COVID-19 pandemic.

This study was intended to report and analyze the University of Washington's Department of Oral and Maxillofacial Surgery's experience with odontogenic infections during the COVID-19 response. It was necessarily limited by drawing data from only two hospitals in the same city, limiting generalizability. Although, UW is the only non-military OMS department in the state and is therefore uniquely positioned to convey data for the state of Washington. The investigators chose to evaluate a 3-month period in order to provide timely data to the ongoing pandemic response and to correspond with Governor Inslee's proclamation which defined elective dentistry as treatment of pathology not likely to cause patient harm within 3 months.

This study was limited in that analysis of years previous was conducted by retrospective chart review. Follow up studies to evaluate a longer time course of pandemic response are necessary.

At the time of preparation of this manuscript, no studies existed to evaluate sequelae of legislative prohibition of elective dentistry in the hospital setting. The pandemic and humanity's response are ongoing and more data will be necessary to both evaluate the effect of actions already taken and to better inform future decisions. Tables   Table 1 . Incidence of OMS consultation for odontogenic infection Table 2 . Bivariate analysis of patient demographics Table 3 . Bivariate analysis of infections J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f 

Proclamation 20-05 (20-24 Restrictions on Non Urgent Medical Procedures)

Proclamation by the Governor Amending Proclamation 20-05 (20-25.6 "Safe start -Stay Healthy" County-by-county Phased Reopening)

Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis

Guidelines for University of Washington Oral and Maxillofacial Surgery Patient Care

Aerosol-generating otolaryngology procedures and the need for enhanced PPE during the COVID-19 pandemic: a literature review

Chronic periodontitis, generalized, severe K05.329 Chronic periodontitis, generalized, unspecified severity